{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:53:45Z","timestamp":1760644425042,"version":"3.41.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1023\/a:1006370603147","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T01:36:27Z","timestamp":1040520987000},"page":"27-39","source":"Crossref","is-referenced-by-count":21,"title":["Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity"],"prefix":"10.1007","volume":"59","author":[{"given":"Qun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Wulfkuhle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoufik","family":"Ouatas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryalice","family":"Stetler-Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S.","family":"Steeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"253968_CR1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Constantino J, Wickerham D, Redmond C, Kavanah M, Cronin W, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieland S, Tan-Chiu E, Ford L, Wolmark N, et al.: Tamoxifen for prevention of breast cancer: report of the National surgical adjuvant breast and bowel project P-1 study. J National Cancer Inst 90: 1371-1388, 1998","journal-title":"J National Cancer Inst"},{"key":"253968_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"W DuPont","year":"1985","unstructured":"DuPont W, Page D: Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312: 146-151, 1985","journal-title":"New Engl J Med"},{"key":"253968_CR3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","volume":"71","author":"W DuPont","year":"1993","unstructured":"DuPont W, Parl F, Hartmann W, Brinton L, Winfeld A, Worrell J, Schuyler P, Plummer W: Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258-1265, 1993","journal-title":"Cancer"},{"key":"253968_CR4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"S London","year":"1992","unstructured":"London S, Connolly J, Schnitt S, Colditz G: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267: 941-944, 1992","journal-title":"JAMA"},{"key":"253968_CR5","first-page":"297","volume":"6","author":"L Marshall","year":"1997","unstructured":"Marshall L, Hunter D, Connolly J, Schnitt S, Byrne C, London S, Colditz G: Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiology, Biomarkers and Prev 6: 297-301, 1997","journal-title":"Cancer Epidemiology, Biomarkers and Prev"},{"key":"253968_CR6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-199212000-00005","volume":"16","author":"GL Otteson","year":"1992","unstructured":"Otteson GL, Graversen HP, Blichert TM, Zedeler K, Andersen JA: Ductal carcinoma in situ of the female breast: short term results of a prospective nationwide study, Amer J Surg Pathol 16: 1183-1196, 1992","journal-title":"Amer J Surg Pathol"},{"key":"253968_CR7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0046-8177(86)80636-0","volume":"17","author":"D Page","year":"1986","unstructured":"Page D: Cancer risk assessment in benign breast biopsies. Human Pathol 17: 871-874, 1986","journal-title":"Human Pathol"},{"key":"253968_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00666428","volume":"28","author":"D Page","year":"1993","unstructured":"Page D, DuPont W: Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat 28: 157-166, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"253968_CR9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/1097-0142(19900201)65:3<518::AID-CNCR2820650324>3.0.CO;2-O","volume":"65","author":"F Tavassoli","year":"1990","unstructured":"Tavassoli F, Norris H: A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65: 518-529, 1990","journal-title":"Cancer"},{"key":"253968_CR10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archsurg.1992.01420120026004","volume":"127","author":"BA Ward","year":"1992","unstructured":"Ward BA, McKhann CF, Ravikkumar TS: Ten year follow-up of breast carcinoma in situ in Connecticut. Archives of Surgery 127: 1392-1395, 1992","journal-title":"Archives of Surgery"},{"key":"253968_CR11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM199902113400604","volume":"340","author":"T Jacobs","year":"1999","unstructured":"Jacobs T, Byrne C, Colditz G, Connolly J, Schnitt S: Radial scars in benign breast-biopsy specimens and the risk of breast cancer. New Engl J Med 340: 430-436, 1999","journal-title":"New Engl J Med"},{"key":"253968_CR12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1295-1257","volume":"1","author":"D Weinstat-Saslow","year":"1995","unstructured":"Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1: 1257-1260, 1995","journal-title":"Nature Med"},{"key":"253968_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1096-9896(199804)184:4<396::AID-PATH1259>3.0.CO;2-G","volume":"184","author":"C Gillett","year":"1998","unstructured":"Gillett C, Lee A, Millis R, Barnes D: Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184: 396-400, 1998","journal-title":"J Pathol"},{"key":"253968_CR14","first-page":"847","volume":"4","author":"K Alle","year":"1998","unstructured":"Alle K, Henshall S, Field A, Sutherland R: Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4: 847-854, 1998","journal-title":"Clin Cancer Res"},{"key":"253968_CR15","first-page":"161","volume":"151","author":"J Simpson","year":"1997","unstructured":"Simpson J, Quan D, O'Malley F, Odom-Maryon T, Clarke P: Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151: 161-168, 1997","journal-title":"Am J Pathol"},{"key":"253968_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<279::AID-PATH240>3.0.CO;2-C","volume":"187","author":"C Vos","year":"1999","unstructured":"Vos C, Haar NT, Peterese J, Cornelisse G, Vijer MVd: Cyclin D-1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol 187: 279-284, 1999","journal-title":"J Pathol"},{"key":"253968_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","volume":"79","author":"T Hunter","year":"1994","unstructured":"Hunter T, Pines J: Cyclins and Cancer II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994","journal-title":"Cell"},{"key":"253968_CR18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"C Sherr","year":"1996","unstructured":"Sherr C: Cancer cell cycles. Science 274: 1672-1677, 1996","journal-title":"Science"},{"key":"253968_CR19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1006\/bbrc.1995.2892","volume":"217","author":"K Asano","year":"1995","unstructured":"Asano K, Sakamoto H, Sasaki H, Ochiya T: Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem Biophys Res Commun 217: 1169-1176, 1995","journal-title":"Biochem Biophys Res Commun"},{"key":"253968_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0896-6273(94)90276-3","volume":"12","author":"R Freeman","year":"1994","unstructured":"Freeman R, Estus S, EM Johnson J: Analysis of cell cyclerelated gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12: 343-355, 1994","journal-title":"Neuron"},{"key":"253968_CR21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1128\/MCB.18.3.1590","volume":"18","author":"K Inoue","year":"1998","unstructured":"Inoue K, Sherr C: Gene expression and cell-cycle arrest mediated by transcription factor DMP1 is antagonized by Dtype cyclins though a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 18: 1590-1600, 1998","journal-title":"Mol Cell Biol"},{"key":"253968_CR22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/j.1460-2075.1996.tb00332.x","volume":"15","author":"O Kranenburg","year":"1996","unstructured":"Kranenburg O, Eb Av, Zantema A: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15: 46-54, 1996","journal-title":"EMBO J"},{"key":"253968_CR23","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/MCB.17.9.5338","volume":"17","author":"E Neuman","year":"1997","unstructured":"Neuman E, Ladha M, Lin N, Upton T, Miller S, Renzo JD, Pestell R, Hinds P, Dowdy S, Brown M, Ewen M: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17: 5338-5347, 1997","journal-title":"Mol Cell Biol"},{"key":"253968_CR24","first-page":"36","volume":"56","author":"P Zhou","year":"1996","unstructured":"Zhou P, Jiang W, Weghorst CM, Weinstein IB: Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36-39, 1996","journal-title":"Cancer Res"},{"key":"253968_CR25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)81879-6","volume":"88","author":"R Zwijsen","year":"1997","unstructured":"Zwijsen R, Wientjens E, Klompmaker R, Sman JVd, Bernards R, Michalides R: CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-415, 1997","journal-title":"Cell"},{"key":"253968_CR26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","volume":"369","author":"T Wang","year":"1994","unstructured":"Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, Schmidt E: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671, 1994","journal-title":"Nature"},{"key":"253968_CR27","unstructured":"Han EK-H, Sgambato A, JiangW, Zhang Y-J, Santella R, Doki Y, Cacace A, Schieren I, Weinstein I: Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 953-961, 1995"},{"key":"253968_CR28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1006529407652","volume":"16","author":"T Kamalati","year":"1998","unstructured":"Kamalati T, Davies D, Titley J, Crompton M: Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells. Clin Exp Metast 16: 415-426, 1998","journal-title":"Clin Exp Metast"},{"key":"253968_CR29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jnci\/85.21.1725","volume":"85","author":"F Miller","year":"1993","unstructured":"Miller F, Soule H, Tait L, Pauley R, Wolman S, Dawson P, Heppner G: Xenograft model of progressive human proliferative breast disease. J Nat'l Cancer Inst 85: 1725-1732, 1993","journal-title":"J Nat'l Cancer Inst"},{"key":"253968_CR30","first-page":"6075","volume":"50","author":"H Soule","year":"1990","unstructured":"Soule H, Maloney T, Wolman S, WD Peterson J, Brenz R, McGrath C, Russo J, Pauley R, Jones R, Brooks S: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990","journal-title":"Cancer Res"},{"key":"253968_CR31","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","volume":"18","author":"J Morgenstern","year":"1990","unstructured":"Morgenstern J, Land H: Advanced mammalian gene transfer: High titer retroviral vectors with multiple drug selection markers and complimentary helper free packaging cell line. Nucl Acids Res 18: 3587-3596, 1990","journal-title":"Nucl Acids Res"},{"key":"253968_CR32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0092-8674(93)90137-F","volume":"73","author":"SF Dowdy","year":"1993","unstructured":"Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499-511, 1993","journal-title":"Cell"},{"key":"253968_CR33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1073\/pnas.91.2.709","volume":"91","author":"PW Hinds","year":"1994","unstructured":"Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA: Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91: 709-713, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"253968_CR34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nm0497-395","volume":"3","author":"JMP Freije","year":"1997","unstructured":"Freije JMP, Lawrence JA, Hollingshead MG, Rosa ADL, Narayanan V, Grever M, Sausville EA, Paull K, Steeg PS: Identification of compounds with preferential in vitro inhibitory activity against low Nm23 expressing human breast carcinoma and melanoma cell lines. Nature Med 3: 395-401, 1997","journal-title":"Nature Med"},{"key":"253968_CR35","first-page":"137","volume-title":"Culture of Animal Cells","author":"R Freshney","year":"1987","unstructured":"Freshney R: Culture of Animal Cells, 2nd edition. Alan R. Liss, Inc. New York, 1987, pp. 137-153","edition":"2nd edition"},{"key":"253968_CR36","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/MCB.16.7.3370","volume":"16","author":"J Kang","year":"1996","unstructured":"Kang J, Krauss R: Ras induces anchorage-independent growth by subverting multiple adhesion regulated cell cycle events. Mol Cell Biol 16: 3370-3380, 1996","journal-title":"Mol Cell Biol"},{"key":"253968_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.onc.1201142","volume":"15","author":"Q Zhou","year":"1997","unstructured":"Zhou Q, Stetler-Stevenson M, Steeg P: Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene 15: 107-115, 1997","journal-title":"Oncogene"},{"key":"253968_CR38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/MCB.16.3.762","volume":"14","author":"M Gorospe","year":"1996","unstructured":"Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ: Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol 14: 762-770, 1996","journal-title":"Mol Cell Biol"},{"key":"253968_CR39","first-page":"313","volume":"148","author":"P Dawson","year":"1996","unstructured":"Dawson P, Wolman S, Tait L, Heppner G, Miller F: MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148: 313-319, 1996","journal-title":"Am J Pathol"},{"key":"253968_CR40","first-page":"699","volume":"7","author":"E-H Han","year":"1996","unstructured":"Han E-H, Begemann M, Sgambato A, Soh J-W, Doki Y, Xing W-Q, Liu W, Weinstein I: Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kipl, inhibits growth and enhances apoptosis. Cell Growth Diff 7: 699-710, 1996","journal-title":"Cell Growth Diff"},{"key":"253968_CR41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"C Sherr","year":"1995","unstructured":"Sherr C, Roberts J: Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 9: 1149-1163, 1995","journal-title":"Genes Dev"},{"key":"253968_CR42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<267::AID-PATH783>3.0.CO;2-X","volume":"181","author":"D Barnes","year":"1997","unstructured":"Barnes D: Cyclin D1 in mammary carcinoma. J Pathol 181: 267-269, 1997","journal-title":"J Pathol"},{"key":"253968_CR43","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/sj.onc.1201080","volume":"14","author":"H Hiyama","year":"1997","unstructured":"Hiyama H, Iavarone A, LaBaer J, Reeves S: Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14: 2533-2542, 1997","journal-title":"Oncogene"},{"key":"253968_CR44","first-page":"775","volume":"12","author":"P Michieli","year":"1996","unstructured":"Michieli P, Li W, Lorenzi M, Miki T, Zakut R, Givol D, Pierce J: Inhibition of oncogene-mediated transformation by ectopic expression of p21 (Waf) in NIH3T3 cells. Oncogene 12: 775-784, 1996","journal-title":"Oncogene"},{"key":"253968_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/1523-1747.ep12276538","volume":"109","author":"M Castellano","year":"1997","unstructured":"Castellano M, Gabrielli B, Hussussian C, Dracopoli N, Hayward N: Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal. J Invest Dermatol 109: 61-68, 1997","journal-title":"J Invest Dermatol"},{"key":"253968_CR46","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/emboj\/18.6.1571","volume":"18","author":"M Cheng","year":"1999","unstructured":"Cheng M, Olivier P, Diehl J, Fero M, Roussel M, Roberts J, Sherr C: The p2lcipl and p27kipl CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18: 1571-1583, 1999","journal-title":"EMBO J"},{"key":"253968_CR47","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1128\/MCB.19.3.1775","volume":"19","author":"D Parry","year":"1999","unstructured":"Parry D, Mahony D, Wills K, Lees E: Cyclin D-CDK subunit arrangement is dependent on availability of competing INK4 and p21 class inhibitors. Moll Cell Biol 19: 1775-1783, 1999","journal-title":"Moll Cell Biol"},{"key":"253968_CR48","first-page":"5053","volume":"58","author":"M Welcker","year":"1998","unstructured":"Welcker M, Lukas J, Strauss M, Bartek J: p21 WAF\/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D\/CDK4 (6) complexes in human tumor cells. Cancer Res 58: 5053-5056, 1998","journal-title":"Cancer Res"},{"key":"253968_CR49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.271.5248.499","volume":"271","author":"F Fang","year":"1996","unstructured":"Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E: Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502, 1996","journal-title":"Science"},{"key":"253968_CR50","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1128\/MCB.17.7.4059","volume":"17","author":"M Plana-Silva","year":"1997","unstructured":"Plana-Silva M, Weinberg R: Estrogen-dependent cyclin Ecdk2 activation through p21 redistribution. Mol Cell Biol 17: 4059-4069, 1997","journal-title":"Mol Cell Biol"},{"key":"253968_CR51","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1128\/MCB.18.8.4499","volume":"18","author":"O Prall","year":"1998","unstructured":"Prall O, Rogan E, Musgrove E, Watts C, Sutherland R: c-myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol Cell Biol 18: 4499-4508, 1998","journal-title":"Mol Cell Biol"},{"key":"253968_CR52","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.96.6.2817","volume":"96","author":"K Lacey","year":"1999","unstructured":"Lacey K, Jackson P, Stearns T: Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96: 2817-2822, 1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"253968_CR53","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/sj.onc.1202352","volume":"17","author":"M Shivji","year":"1999","unstructured":"Shivji M, Ferrari E, Ball K, Hubacher U, Wood R: Resistance of human nucleotide excision repair synthesis in vitro to p21 cdnl. Oncogene 17: 2827-2838, 1999","journal-title":"Oncogene"},{"key":"253968_CR54","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1128\/MCB.18.8.4526","volume":"18","author":"W Seghezzi","year":"1998","unstructured":"Seghezzi W, Chua K, Shanahan F, Reed G, Lees E: Cyclin E associates with components of pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol 18: 4526-4536, 1998","journal-title":"Mol Cell Biol"},{"key":"253968_CR55","first-page":"167","volume":"150","author":"J Lukas","year":"1997","unstructured":"Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen W, Felix J, Jones L, Hall F, Press M: WAF1\/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol 150: 167-175, 1997","journal-title":"Am J Pathol"},{"key":"253968_CR56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/bjc.1996.339","volume":"74","author":"M Barbareschi","year":"1996","unstructured":"Barbareschi M, Caffo O, Doglioni C, Fina P, Marchetti A, Buttitta F, Leek R, Morelli L, Leonardi E, Bevilacqua G, Dallapalma P, Harris A: p21 (WAF1) immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer 74: 208-215, 1996","journal-title":"Br J Cancer"},{"key":"253968_CR57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/bbrc.1997.7267","volume":"238","author":"T Kuzumaki","year":"1997","unstructured":"Kuzumaki T, Ishikawa K: Loss of cell adhesion to substratum up-regulates p21 (Cip1\/WAF1) expression in BALB\/c3T3 fibroblasts. Biochem Biophys Res Comm 238: 169-172, 1997","journal-title":"Biochem Biophys Res Comm"},{"key":"253968_CR58","doi-asserted-by":"crossref","first-page":"29091","DOI":"10.1074\/jbc.272.46.29091","volume":"272","author":"R Wu","year":"1997","unstructured":"Wu R, Schonthal A: Activation of p53-p21waf1 pathway in response to disruption of cell-matrix interactions. J Biol Chem 272: 29091-29098, 1997","journal-title":"J Biol Chem"},{"key":"253968_CR59","first-page":"355","volume":"12","author":"S Bardon","year":"1998","unstructured":"Bardon S, Razanamahefa L: Retinoic acid suppresses insulininduced growth and cyclin D1 gene expression in human breast cancer cells. Int J Oncol 12: 355-359, 1998","journal-title":"Int J Oncol"},{"key":"253968_CR60","first-page":"631","volume":"8","author":"V Seewaldt","year":"1997","unstructured":"Seewaldt V, Kim J-H, Caldwell L, Johnson B, Swisshelm K, Collins S: All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Diff 8: 631-641, 1997","journal-title":"Cell Growth Diff"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006370603147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006370603147\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006370603147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006370603147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:33:32Z","timestamp":1750480412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006370603147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["253968"],"URL":"https:\/\/doi.org\/10.1023\/a:1006370603147","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}